147 related articles for article (PubMed ID: 16729897)
1. The expression of p63 is associated with the differential stage in nasopharyngeal carcinoma and EBV infection.
Guo C; Pan ZG; Li DJ; Yun JP; Zheng MZ; Hu ZY; Cheng LZ; Zeng YX
J Transl Med; 2006 May; 4():23. PubMed ID: 16729897
[TBL] [Abstract][Full Text] [Related]
2. [Expression of CD25+ lymphocytes in nasopharyngeal carcinoma and its association with EBV infection].
Liu W; Han HX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):94-7. PubMed ID: 16495186
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma.
Niemhom S; Kitazawa S; Kitazawa R; Maeda S; Leopairat J
Cancer Detect Prev; 2008; 32(2):127-34. PubMed ID: 18632221
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Epstein-Barr virus genotypes and clinicohistopathological features of nasopharyngeal carcinoma between Guilin, China and Fukuoka, Japan.
Zhou Y; Nabeshima K; Koga K; Aoki M; Hayashi H; Hamasaki M; Iwasaki H
Oncol Rep; 2008 Jun; 19(6):1413-20. PubMed ID: 18497945
[TBL] [Abstract][Full Text] [Related]
5. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Epstein-Barr virus A73 gene in nasopharyngeal carcinoma tissues and its subcellular location].
Li A; Zhang XS; Wang HH; Jiang JH; Liu XQ; Liu QC; Zeng YX
Ai Zheng; 2003 Jun; 22(6):597-601. PubMed ID: 12948408
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis.
Fan SQ; Ma J; Zhou J; Xiong W; Xiao BY; Zhang WL; Tan C; Li XL; Shen SR; Zhou M; Zhang QH; Ou YJ; Zhuo HD; Fan S; Zhou YH; Li GY
Hum Pathol; 2006 May; 37(5):593-605. PubMed ID: 16647958
[TBL] [Abstract][Full Text] [Related]
8. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
Mirzamani N; Salehian P; Farhadi M; Tehran EA
Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
[TBL] [Abstract][Full Text] [Related]
9. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma.
Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P
J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009
[TBL] [Abstract][Full Text] [Related]
13. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
[TBL] [Abstract][Full Text] [Related]
15. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
Tiwawech D; Srivatanakul P; Karalak A; Ishida T
J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
17. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
Chen CL; Ou DL
Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
[TBL] [Abstract][Full Text] [Related]
18. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
19. New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China.
Ji KM; Li CL; Meng G; Han AD; Wu XL
Arch Virol; 2008; 153(10):1949-53. PubMed ID: 18807115
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of nasopharyngeal carcinoma-type EBV infection induces tumorigenicity.
Seto E; Ooka T; Middeldorp J; Takada K
Cancer Res; 2008 Feb; 68(4):1030-6. PubMed ID: 18281477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
